AI generated summary of Pubmed citation/abstract with PMID 38093452

https://pubmed.ncbi.nlm.nih.gov/38093452
Agomelatine, a melatonin receptor agonist, mitigates doxorubicin-induced brain injury by reducing inflammation and oxidative stress, and preventing apoptosis in a dose-dependent manner.